Mei-Jung Lai

831 total citations
27 papers, 694 citations indexed

About

Mei-Jung Lai is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mei-Jung Lai has authored 27 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Mei-Jung Lai's work include Histone Deacetylase Inhibitors Research (16 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (9 papers). Mei-Jung Lai is often cited by papers focused on Histone Deacetylase Inhibitors Research (16 papers), Peptidase Inhibition and Analysis (10 papers) and Protein Degradation and Inhibitors (9 papers). Mei-Jung Lai collaborates with scholars based in Taiwan, United States and Germany. Mei-Jung Lai's co-authors include Jing‐Ping Liou, Hsueh‐Yun Lee, Kunal Nepali, Kai‐Cheng Hsu, Tony Eight Lin, Shiow‐Lin Pan, Hsiang-Ling Huang, Chia‐Ron Yang, Yi-Min Liu and Han-Li Huang and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Mei-Jung Lai

27 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei-Jung Lai Taiwan 17 526 261 200 66 40 27 694
Peter Chua Canada 11 443 0.8× 323 1.2× 111 0.6× 29 0.4× 28 0.7× 14 766
Sukumar Sakamuri United States 13 393 0.7× 330 1.3× 154 0.8× 116 1.8× 65 1.6× 24 724
Barri Wautlet United States 9 191 0.4× 152 0.6× 119 0.6× 43 0.7× 21 0.5× 11 414
Eric Ferrandis France 16 412 0.8× 320 1.2× 137 0.7× 37 0.6× 18 0.5× 27 761
Ming Guo China 8 353 0.7× 132 0.5× 134 0.7× 20 0.3× 28 0.7× 14 540
Tina Morgan Ross United States 9 453 0.9× 140 0.5× 322 1.6× 108 1.6× 40 1.0× 14 749
Yuya Oguro Japan 11 263 0.5× 205 0.8× 99 0.5× 28 0.4× 40 1.0× 15 450
Peter F. Bousquet United States 15 300 0.6× 258 1.0× 109 0.5× 20 0.3× 26 0.7× 21 561
Stephen M. Courtney United Kingdom 12 346 0.7× 215 0.8× 95 0.5× 28 0.4× 34 0.8× 15 572
Junping Pei China 10 316 0.6× 112 0.4× 117 0.6× 24 0.4× 26 0.7× 24 523

Countries citing papers authored by Mei-Jung Lai

Since Specialization
Citations

This map shows the geographic impact of Mei-Jung Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Jung Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Jung Lai more than expected).

Fields of papers citing papers by Mei-Jung Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Jung Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Jung Lai. The network helps show where Mei-Jung Lai may publish in the future.

Co-authorship network of co-authors of Mei-Jung Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Mei-Jung Lai. A scholar is included among the top collaborators of Mei-Jung Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei-Jung Lai. Mei-Jung Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upadhyay, Richa, et al.. (2024). Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agents. Bioorganic Chemistry. 153. 107771–107771. 2 indexed citations
2.
Chen, I‐Chung, Mei-Jung Lai, Zhengyang Liu, et al.. (2024). HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids. European Journal of Medicinal Chemistry. 278. 116801–116801. 6 indexed citations
3.
Liu, Yi-Min, Huang‐Ju Tu, Mei-Jung Lai, et al.. (2021). Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo. European Journal of Medicinal Chemistry. 219. 113428–113428. 14 indexed citations
4.
Nepali, Kunal, Tsung‐I Hsu, Chien‐Ming Hsieh, et al.. (2021). Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma. European Journal of Medicinal Chemistry. 217. 113338–113338. 18 indexed citations
5.
Singh, Arshdeep, Ting-Yu Chang, Navdeep Kaur, et al.. (2021). CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition. European Journal of Medicinal Chemistry. 215. 113169–113169. 31 indexed citations
6.
Mehndiratta, Samir, et al.. (2020). Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 74–84. 10 indexed citations
7.
Ojha, Ritu, Kunal Nepali, Chun‐Han Chen, et al.. (2020). Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 190. 112086–112086. 35 indexed citations
8.
9.
Nepali, Kunal, Ting-Yu Chang, Mei-Jung Lai, et al.. (2020). Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors. European Journal of Medicinal Chemistry. 196. 112291–112291. 37 indexed citations
10.
Nepali, Kunal, Mei-Hsiang Lin, Min‐Wu Chao, et al.. (2019). Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells. Bioorganic Chemistry. 91. 103119–103119. 17 indexed citations
11.
Chao, Min‐Wu, Huang‐Ju Tu, Mei-Jung Lai, et al.. (2019). Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Clinical Epigenetics. 11(1). 85–85. 28 indexed citations
12.
Kaur, Navdeep, Hsueh‐Yun Lee, Arshdeep Singh, et al.. (2019). Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment. European Journal of Medicinal Chemistry. 187. 111915–111915. 14 indexed citations
13.
Lai, Mei-Jung, Ritu Ojha, Mei-Hsiang Lin, et al.. (2018). 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. European Journal of Medicinal Chemistry. 162. 612–630. 37 indexed citations
14.
Ojha, Ritu, Han-Li Huang, Wei‐Chun HuangFu, et al.. (2018). 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. European Journal of Medicinal Chemistry. 150. 667–677. 48 indexed citations
15.
Liu, Yi-Min, Wei‐Chun HuangFu, Han-Li Huang, et al.. (2017). 1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma. European Journal of Medicinal Chemistry. 140. 84–91. 16 indexed citations
16.
Lee, Hsueh‐Yun, Sunil Kumar, Wei‐Chun HuangFu, et al.. (2016). 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity. European Journal of Medicinal Chemistry. 125. 1268–1278. 40 indexed citations
17.
Lee, Hsueh‐Yun, C.S. Chang, Mei-Jung Lai, et al.. (2015). Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes. Bioorganic & Medicinal Chemistry. 23(15). 4230–4236. 13 indexed citations
18.
19.
Lai, Mei-Jung, Han-Li Huang, Shiow‐Lin Pan, et al.. (2012). Synthesis and Biological Evaluation of 1-Arylsulfonyl-5-(N-hydroxyacrylamide)indoles as Potent Histone Deacetylase Inhibitors with Antitumor Activity in Vivo. Journal of Medicinal Chemistry. 55(8). 3777–3791. 55 indexed citations
20.
Lee, Hsueh‐Yun, Jang‐Yang Chang, Ling‐Yin Chang, et al.. (2011). Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation. Organic & Biomolecular Chemistry. 9(9). 3154–3154. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Chua Breakdown of academic impact, for papers by Sukumar Sakamuri Breakdown of academic impact, for papers by Barri Wautlet Breakdown of academic impact, for papers by Eric Ferrandis Breakdown of academic impact, for papers by Ming Guo Breakdown of academic impact, for papers by Tina Morgan Ross Breakdown of academic impact, for papers by Yuya Oguro Breakdown of academic impact, for papers by Peter F. Bousquet Breakdown of academic impact, for papers by Stephen M. Courtney Breakdown of academic impact, for papers by Junping Pei
Rankless by CCL
2026